Skip to content

The research of esketamine combined with ultrasound-guided brachial plexus block for shoulder arthroscopy

The research of esketamine combined with ultrasound-guided brachial plexus block for shoulder arthroscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047355
Enrollment
Unknown
Registered
2021-06-12
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder joint disease

Interventions

Group 2:Esketamine + nerve block

Sponsors

The First People’s Hospital of Yancheng
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective shoulder surgery; 2. Aged 30-65 years, BMI 18-30kg/m^2, ASA I or II.

Exclusion criteria

Exclusion criteria: 1. Patients with central nervous system or mental illness before surgery; 2. Severe internal environment disorder and insufficiency of heart, lung, liver, and kidney; 3. Those with severe visual impairment or hearing impairment who cannot communicate; 4. Patients with broken skin infection or systemic infection symptoms in the anesthesia operation area; 5. Patients with coagulation dysfunction; 6. Those who have a history of motion sickness and smoking.

Design outcomes

Primary

MeasureTime frame
Visual analogue score;Diaphragm mobility;Amount of remedial medication;Vertigo;Nausea and vomiting;Pruritus;Mean arterial pressure;Heart rate;Pulse oxygen;Age;

Secondary

MeasureTime frame
ASA grade;Body mass index;Operation time;Amount of bleeding;

Countries

China

Contacts

Public ContactLiu Xiang

The First People's Hospital of Yancheng

313785609@qq.com+86 13615161345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026